GL1X · GenesisL1 explorer

Research workbench

Crystal structure of a class C beta-lactamase in complex with cefotaxime

Analyse Crystal structure of a class C beta-lactamase in complex with cefotaxime in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
6K9T
Type
protein
Length
358 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v2 / PDB Bank
Contract
0xd58B01f6C18086e5202cdC5D7Ad3E41790360102
Owner
0xF4e1AA6f26B7DA48EeAD9B24a97927303eeA07b8
Resolution
1.459
Source
Klebsiella pneumoniae
Molecule
Beta-lactamase
EC
3.5.2.6
UniProt
Q9XB24
Ligands
CEF
Pockets
2 · best druggability 0.58

Structure

x-ray diffraction · resolution 1.459 · 1 distinct chain · 40% helix, 24% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase (EC 3.5.2.6)protein35840% helix, 24% strandQ9XB24

Ligands and binding sites

  • CEF · CEFOTAXIME, C3' cleaved, open, bound form · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
13120.580.7743CEF
2900.330.7322empty

Modifications

Observed in the structure: 1 covalent (covalent ligand).

Compared structures

  • 6K9T · Crystal structure of a class C beta-lactamase in complex with cefotaxime · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.